Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study.
about
Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomesWithholding statins in patients with underlying liver disease: wise or unwise?Statin use in patients with cirrhosis: a retrospective cohort study.Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis CEffects of statins on the risk of hepatocellular carcinomaBeneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.Drug-Induced Liver Injury: Pattern Recognition and Future Directions.Drug-induced liver injury: what was new in 2008?Statin-induced cholestatic hepatitis: confirmed on rechallenge.Clinical perspective: statins and the liver--harmful or helpful?Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapy.Statin-induced liver injury in an area endemic for hepatitis B virus infection: risk factors and outcome analysis.Statin therapy and serum transaminases among a cohort of HCV-infected veterans.Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study.Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?Evaluation of Statin Treatment for Nonalcoholic Fatty Liver Disease.
P2860
Q28081216-0A901ABC-6BC6-45DA-9A8D-9CFE6630A263Q33763729-437E31F5-A5A3-4C05-85D4-D23371F328A1Q34661975-0102CDDC-5D9C-4336-B45C-2C2E088A4E86Q34747195-EB98C523-4020-4E54-8965-F670E7AEC2E1Q34997752-3BD54F0E-F345-4F12-AAA9-452DF2F0D976Q36393781-C7CF5DFD-E2F6-450C-B224-A5D1331FD77FQ36412863-75F52342-7661-4766-BED8-5196BF207431Q37510856-0E702876-E5BC-4DFB-833B-9CA52D3B5629Q37698493-819B6C10-435B-450B-9DF0-F883AC7EF7F4Q38009719-3F50C337-C698-40F8-A2EF-2EEA450F4916Q38166445-139C5D0A-B51C-4D02-9A4F-90607EF5A0B3Q39752811-F58C2E1C-CC15-4D87-A393-4302609361D0Q41345786-075A9A32-92AC-43E1-B395-78DBD8AE6251Q44324185-1A6F5899-9B7F-4549-977E-0441E23ED8E0Q46131886-FD9D2081-CC97-41B1-A13A-90E9FACDE53EQ55265845-C61AD5C6-FC7D-44C8-B5D5-7916D4355CB7
P2860
Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Hepatic effects of lovastatin ...... a retrospective cohort study.
@en
Hepatic effects of lovastatin ...... a retrospective cohort study.
@nl
type
label
Hepatic effects of lovastatin ...... a retrospective cohort study.
@en
Hepatic effects of lovastatin ...... a retrospective cohort study.
@nl
prefLabel
Hepatic effects of lovastatin ...... a retrospective cohort study.
@en
Hepatic effects of lovastatin ...... a retrospective cohort study.
@nl
P2093
P1433
P1476
Hepatic effects of lovastatin ...... a retrospective cohort study.
@en
P2093
Amy Replogle
Andrew L Avins
Douglas J Watson
Jeffrey G Levine
Lynn Ackerson
Michele M Manos
Peggy M T Hwang
Rosemary Murphy
Theodore R Levin
P304
P356
10.2165/00002018-200831040-00006
P577
2008-01-01T00:00:00Z
P6179
1009071655